Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort
K Ritzel, J Fazel, L August, V Fedtke… - The Journal of …, 2024 - academic.oup.com
Background Normalization of hypercortisolism is essential to reduce morbidity and mortality
in patients with Cushing's syndrome (CS). The aim of this analysis was to assess …
in patients with Cushing's syndrome (CS). The aim of this analysis was to assess …
Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review
S Puglisi, AME Perini, C Botto, F Oliva… - The Journal of Clinical …, 2024 - academic.oup.com
It is held that the condition of endogenous chronic hypersecretion of cortisol (Cushing
syndrome, CS), causes several comorbidities, including cardiovascular and metabolic …
syndrome, CS), causes several comorbidities, including cardiovascular and metabolic …
Medical therapy for Cushing's syndrome in the twenty-first century
NA Tritos, BMK Biller - Endocrinology and Metabolism Clinics, 2018 - endo.theclinics.com
Prompt control of hypercortisolism is needed to reverse clinical and biochemical
manifestations and decrease excess morbidity and mortality in patients with endogenous …
manifestations and decrease excess morbidity and mortality in patients with endogenous …
Management of hypercortisolism
C Rosales, H Fierrard, X Bertagna… - La Revue de …, 2008 - europepmc.org
Purpose Cushing's syndrome is a rare but frequently considered disease. Its diagnosis can
lead to some difficulties, including confirming the effective endogenous hypercortisolism and …
lead to some difficulties, including confirming the effective endogenous hypercortisolism and …
Medical management of Cushing's disease: When and how?
F Castinetti - Journal of Neuroendocrinology, 2022 - Wiley Online Library
Transsphenoidal surgery is the first‐line treatment of Cushing's disease. However, medical
treatment can be given in a high proportion of patients with this rare condition. This is …
treatment can be given in a high proportion of patients with this rare condition. This is …
Cushing's syndrome–Disease monitoring: Recurrence, surveillance with biomarkers or imaging studies
O Ragnarsson - Best Practice & Research Clinical Endocrinology & …, 2020 - Elsevier
Pituitary surgery is the first-line treatment for patients with Cushing's disease. For patients
who are not considered candidates for pituitary surgery, pituitary radiation and bilateral …
who are not considered candidates for pituitary surgery, pituitary radiation and bilateral …
Biochemical control during long-term follow-up of 230 adult patients with Cushing disease: a multicenter retrospective study
EB Geer, I Shafiq, MB Gordon, V Bonert, A Ayala… - Endocrine Practice, 2017 - Elsevier
Objective: Cushing disease (CD) results from excessive exposure to glucocorticoids caused
by an adrenocorticotropic hormone–secreting pituitary tumor. Inadequately treated CD is …
by an adrenocorticotropic hormone–secreting pituitary tumor. Inadequately treated CD is …
Optimal management of Cushing syndrome
EG Durán-Pérez, OT Moreno-Loza… - … and Reports in …, 2012 - Taylor & Francis
Cushing syndrome (CS) caused by endogenous hypercortisolism is a diagnostic challenge.
The most common cause is Cushing disease. Surgical treatment is the first-line therapy for …
The most common cause is Cushing disease. Surgical treatment is the first-line therapy for …
[PDF][PDF] Cushing's Syndrome: Challenges in Diagnosis and Management
KJ Shetty, R Spurgeon - Chapter 65,, 2013 - Citeseer
Endogenous hypercortisolism is characteristically a condition that should be diagnosed and
treated in tertiary care centers with the participation of several specialists. Cushing's …
treated in tertiary care centers with the participation of several specialists. Cushing's …
Cushing's syndrome: A historic review of the treatment strategies and corresponding outcomes in a single tertiary center over the past half-century
A Nankova, M Yaneva, A Elenkova… - Hormone and …, 2018 - thieme-connect.com
Cushing's syndrome (CS) is associated with serious comorbidities and an increased
mortality rate that could be reduced only if strict biochemical control is achieved. The aim of …
mortality rate that could be reduced only if strict biochemical control is achieved. The aim of …
相关搜索
- cushing's syndrome biochemical control
- cushing's syndrome outcomes of the treatment
- cushing's syndrome center cohort
- outcomes of the treatment biochemical control
- center cohort biochemical control
- center cohort outcomes of the treatment
- medical therapy for cushing's syndrome
- cushing's syndrome italian endocrinologists
- cushing's syndrome delphi panel
- cushing's syndrome disease monitoring
- optimal management cushing syndrome
- cushing's syndrome treatment strategies
- medical management of cushing's disease